Special notice, 8(a) sole source
Vitros XT3400 Chemistry Analyzer and Reagents
12089379-0001
Defense Health Agency (Dha), Defense Health Agency. In-Vitro Diagnostic Substance Manufacturing.
Response deadline
May 15, 2024 at 10:00 AM EDT
Closed 901 days ago. Posted May 10, 2024. Scheduled to archive May 30, 2024.
Get the next one like this from Defense Health Agency (Dha) by email, the day it is posted.Find my opportunities
This one closed in 2024
13 like it are open now in in-vitro diagnostic substance manufacturing
- NOI - DNA Sequencing of Bone Marrow Failure Syndro
National Institutes of Health, National Institutes of Health Olao
Combined synopsis and solicitationNAICS 325413Anywhere in the US75N98027Q00027Closes todayNov 2 - HEMOCHRON SIGNATURE ELITE REAGENTS AND SUPPLIES
Department of Veterans Affairs, 262-Network Contract Office 22
Sources soughtNAICS 325413Anywhere in the US36C26227Q0046Closes todayNov 2 - DRESSING, DRAWTEX 4IN X 4IN (VA-27-00014447)
Department of Veterans Affairs, National Cmop Office
Sources soughtNAICS 325413Anywhere in the US36C77027Q0015Closes tomorrowNov 3
Description
As published on SAM.gov.
THIS IS A SYNOPSIS. THIS IS NOT A REQUEST FOR QUOTE/PROPOSAL – Defense Health Agency (DHA) Northeastern Markets Contracting Division (NM-CD) on behalf of Naval Health Clinic, Quantico (NHCQ) intends to award a firm fixed price contract on a sole source basis to Ortho Clinical Diagnostics, Inc. located at, 1001 Us Highway 202 Raritan, New Jersey 08869-1424.
The anticipated award will be made under the statutory authority permitting Other than Full and Open Competition, FAR 13.106-1(b), soliciting from a single source. The contract is for a cost-per-test or cost-per-reportable service contract for one (1) Vitros XT 3400 Analyzer, Laboratory, Chemistry, reagents, quality control, maintenance, and consumables for Naval Health Clinic, Quantico (NHCQ).
The contracted unit shall be capable of performing general chemistry testing for a minimum annual workload of 10,000 specimens. The analyzer shall be capable of preforming the tests listed in the Statement of Work (SOW) with the minimum workload indicated. The vendor shall provide installation, conduct validation testing, on-site and off-site user training and preventive maintenance coverage.
The analyzer validation includes normal range verification, demonstration of linearity, reportable range, replication studies, recovery studies and establishment of initial control ranges using control materials. The NAICS Code for this requirement is 25413 In-Vitro Diagnostic Substance Manufacturing with a Small Business Size Standard of 1250 Employees. This notice of intent is NOT a request for competitive quotations. Requests for copies of a solicitation in response to this notice will not be honored or acknowledged.
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
May 10, 2024
Special notice
Due May 15, 2024 at 10:00 AM EDT. SAM.gov, notice 32185de2f754409da8ea8a4e78a92776
Points of contact
- Vondae Donaldsonvondae.l.donaldson.ctr@health.mil7032756330
- Edgar DuCheminedgar.r.duchemin.civ@health.mil7032756348